A study involving cardiac and hyperlipoproteinemic outpatients was carried out to determine whether medication compliance was affected by additional medication instruction provided by a pharmacist.
Introduction
DRUG THERAPY is AN IMPORTANT PART of many patients' medical management. Specific biological and chemical agents are frequently prescribed by the physician based upon the needs of the patient. The therapeutic effectiveness of these agents initially depends upon their proper administration to the patient at specific intervals and in definite quantities.
This does not usually present a problem as far as the hospitalized patient is concerned. The physician prescribes, the pharmacist dispenses, and the nurse administers the medication. The patient is completely relieved of any responsibility for controlling his drug therapy. A serious problem may arise, however, in drug therapy for the outpatient. Again the physician prescribes and the pharmacist dispenses the medication, but here the similarity ends. The outpatient, in most cases, has the sole responsibility for administering his own medication prescribed by the physician, and it is assumed he will follow the specified regimen.
Studies have shown, however, that the outpatient often omits taking the prescribed medication or takes it incorrectly. Wilcox, 1 in analyzing the urine of psychiatric outpatients for the presence of promazine and/or imipramine metabolites, found 48 percent of 125 outpatients not taking the medication as prescribed. Similarly, Bergman 2 found a high percentage of noncompliance in 59 children receiving a ten-day regimen of oral penicillin. Their results showed that by the ninth day of therapy, 82 percent of the children had stopped taking the penicillin. Dixon, 8 in determining the frequency which tuberculous patients took PAS, also found a high rate of noncompliance. In a different approach for determining compliance, Watkins 4 observed diabetic patients administering insulin in their homes. This study found that 58 percent of 115 patients made dosage errors. An investigation by Nugent 5 into the toxicities of steroids when lengthening the interval between doses found noncompliance a serious problem. Elderly, chronically ill outpatients were also guilty of misusing prescribed medication. Schwartz 6 interviewed 220 randomly selected elderly outpatients concerning their use of medication. The study found that 47 percent frequently omitted taking their medication.
These studies revealed that outpatients being treated for many different disorders with various medications frequently are unreliable in following a prescribed dosage regimen. Stewart 7 in an article dealing with outpatient medication stated that there are indications which suggest noncompliance is becoming a major problem with our health care system.
There have been a number of proposals as to why outpatients often omit taking prescribed medication, including forgetfulness, demographic factors, undesirable side effects, psychological reasons, poor instructions and lack of medication knowledge. A number of studies have attempted to show that one or possibly a combination of these factors interfere with compliance. Forgetfulness was the most frequently cited reason in a study by Moulding. 8 Berry, 9 in a study involving tuberculous patients, suggested reliability may be associated with marital status, age, education and race. Undesirable side effects appeared to have kept another group of tuberculous patients from taking their PAS regularly. 3 Psychological reasons have also been attributed to omittance. Davis 10 stated in his study that the physician's instructions, no matter how simple, may cause some dissonance with the patient's life style which may result in his refusal to follow a specified regimen. Inadequate and/or confusing instructions by the physician have also been implicated. 11 Latiolais, 12 in his study of medication errors made by outpatients, found that the most prevalent reason for medication misuse, 33 percent of total errors, was due to the patient misunderstanding instructions. In another study by Curtis 13 it was found that of the 16 patients making errors, only 37 percent had accurate knowledge of the purpose of the drug, while of the 10 patients with no errors, 60 percent knew the prupose of the medication.
Mohler's 14 study in patient compliance and Griener's 15 research in patient discharge planning support the assumption that if the patient is given the opportunity to understand the rationale behind the medication, and if explicit directions concerning methods of administration and dosage regimen are provided, compliance may increase.
The physician usually provides the patient with information concerning his medication when the prescription is written, yet it is not uncommon for the patient to mis-Drug Intelligence and Clinical Pharmacy VOL 8
interpret or quickly forget. Therefore, instructions should be given again when the prescription is filled and dispensed. This procedure could clarify any misunderstanding the patient may have concerning his drug therapy and would reinforce the need for explicit compliance to his prescribed medication regimen. The patient should receive this additional information from someone knowledgeable concerning the uses, side effects, dosages, and contraindication of drugs. Since the pharmacist possesses this knowledge and is capable of expanding his role into patient-oriented activities, he seems the logical one to assume this function. This research attempted to determine if comprehensive instruction provided by a pharmacist concerning the proper use of prescribed medication to outpatients would decrease medication errors. The samples employed by this study consisted of cardiac and hyperlipoproteinemic outpatients from the Tucson Veterans Administration Hospital. The following hypothesis was investigated:
No difference in medication errors exists between groups of cardiac and hyperlipoproteinemic outpatients who received comprehensive instruction by a pharmacist and their respective control groups who do not receive such instruction.
Method
This study employed a randomized, single factor design in testing the hypothesis. Accordingly, definitive factors affecting the behavior of a defined and randomly selected experimental group were held constant. This experimental group was then subjected to instruction and its subsequent behavior was compared with that of a control group. Any difference in behavior was then attributed to the treatment.
This design required that the sample be approximately homogenous. 16 Therefore, the selection of a sample involved several considerations. The first decision was to eliminate variables in the number of medications, the kinds of medication, and various dosage schedules. Studies by Vere, 17 Dixon 3 and Clinite 18 have shown that these factors are difficult to statistically compare.
To avoid these variables it was decided to select patients based upon the medication they were prescribed. This led to a second consideration because few patients receive the same medication with the same instructions.
To secure a homogenous sample, a hospital with a large, active outpatient clinic had to be selected as the site for the study. The Tucson Veterans Administration Hospital was the only hospital in the city that could meet this criteria.
The cardiac clinic at the Veterans Administration Hospital was the most active of the outpatient clinics. Consequently, cardiac patients were screened as a potential sample. Over 300 patient charts were reviewed to determine how many patients were receiving the same medication. Fourteen patients were found to be taking digoxin, furosemide or hydrochlorothiazide, and potassium chloride or triamterene. These 14 cardiac patients were selected for this study. It was decided, however, to base the results on only the digoxin and the diuretic errors. The potassium supplement errors were not included because some patients received elixir KC1 and others received triamterene. Since these two drugs were dispensed in different dosage forms, an accurate determination of compliance would have been difficult. It should be noted, however, that Brook 19 has shown a higher degree of noncompliance with potassium chloride than digitalis and a diuretic.
The 14 cardiac patients were randomly divided, by means of a random table, into a control group and an experimental group.
Patients with different medical conditions may react differently to instructions by a pharmacist. Therefore, a comparison of patients with two different conditions receiving different medication was attempted to provide a greater insight into the effects of medication instruction by a pharmacist. This necessitated the securing of a second sample of patients all taking similar medication. Again, the problem of locating a sample meeting certain criteria existed. Fortunately, a cardiologist and an endocrinologist at the Veterans Administration Hospital, in conjunction with Merck, Sharp and Dohme Laboratories, were conducting a controlled, double-blind, clinical study with an experimental agent, halofenate, and clofibrate. Their study involved patients receiving either halofenate and a placebo, or clofibrate and a placebo. The placeboes appeared to be active drugs, so it was impossible for either the physician or the patient to know which was the active drug and which was the placebo.
Since all these patients received the same medication in appearance and dosage, it was decided to include this second sample in this study. Twenty randomly selected hyperlipoproteinemic patients taking the two drugs were randomly divided into control and experimental groups.
All cardiac and hyperlipoproteinemic patients included in this research were initially seen by the investigator just before the clinic began. During this initial interview the investigator introduced himself as a pharmacist and a graduate student. The investigator then explained that he was involved in research and would like to visit the patient at his home in 20 days.
During the initial clinic interview, those patients assigned to the groups not receiving instruction were asked if they were taking the medication they received at their last clinic visit. Those patients in the cardiac groups not receiving instruction were told to have their prescriptions filled and to take only the the newly filled medication. The Veterans Administration Hospital Pharmacy dispenses only a 30-day supply of medication which is prepacked. This provided the investigator an easy assessment of how much medication each patient Was receiving. Patients in the hyperlipoproteinemic group not receiving instruction were given a new month's supply of medication at this initial interview. This medication had been precounted by Merck, Sharp and Dohme Laboratories which again provided easy assessment.
During the initial clinic interview, those patients assigned to the groups receiving instruction were asked to return to the investigator after seeing the physician and before leaving the hospital. After each patient in the cardiac instructed group saw a physician, the investigator took the patient's prescriptions to the pharmacy to be filled. Patients in the hyperlipoproteinemic instructed group did not have to wait for their prescriptions to be filled after seeing the physician. The medication for the hyperlipoproteinemic patients had been labeled the previous night and was taken to the outpatient clinic before the clinic began.
With the medication in hand, the investigator again summoned each patient to be instructed to the examining room. The investigator took each medication separately, displayed the medication so that the patient could see the size, shape and color, then proceeded to instruct the patient in the proper use. Each medication was dealt with similarly. The instruction sheet outlines the procedure provided each patient for each medication. This procedure however was only a guideline because the investigator found early in the study that instructions had to be individualized for each patient, depending upon the patient's depth of understanding. Generally, a positive approach to counseling each patient was employed.
Twenty days following the clinic visit, each patient was seen in his home. Upon entering the home, the investigator asked to be shown all the medication the patient was taking and where it was kept. This procedure was followed to determine if the patient was taking medication other than that which was prescribed. A structured interview (see Patient Identification and Interview) was then closely followed in collecting data. Toward the end of the interview, the investigator counted the. remaining prescription medication with an Abbott pill tray.
Data compiled for each patient was analyzed to determine if further instruction provided by a pharmacist had increased compliance.
Compliance in this study was determined by comparing the amount of medication remaining at the end of 20 days to the amount that should be remaining if the medication was taken as prescribed. Each dose in excess or missed was tabulated as an error. For instance, a patient in the hyperlipoproteinemic group receiving one dose of halofenate daily and two doses of clofibrate daily could have made a maximum of 60 errors in a 20-day period if neither of the drugs was taken. If there was an excess of medication remaining, it was assumed the patient took less than the prescribed dose or omitted doses completely. Similarly, if there was a shortage of medication remaining, it was assumed the patient took more medication than was prescribed.
The definition of an error in this study also included prescription medication that had been discontinued by the physician but was still being taken by the patient. During the collection of data, none of the patients interviewed admitted to taking other prescription medication nor did the investigator see other prescribed medication when shown where the medication was kept in the house. It was assumed from these findings that the use of discontinued prescription medication did not occur in this study.
This type of drug misuse does exist, however. Malahy 20 found 13 discontinued medication errors among her sample of 40 patients having diversified medical problems. One patient had continued to take an oral hypoglycémie agent unknown by the attending resident. Another patient suffering from gastrointestinal disturbances was taking prescribed aspirin for his arthritis without the knowledge of the attending physician. Latiolais 12 in the study of medication misuse also found this to be a problem. Discontinued medication accounted for 8 of 105 total errors among a cross-section of 180 indigent patients.
Results
In tabulating errors, the cardiac uninstructed group was labeled I and the cardiac instructed group was labeled II for easy identification. The hyperlipoproteinemic sample was similarly comprised of two groups and were labeled III, uninstructed group and IV, instructed group. Data obtained during the home interview appears in Tables 1 through 4 .
The seven patients in Group I misused digoxin 35.7 percent or 50 of 140 total doses. Errors involving the diuretic were also high in this group. The seven patients erred on 36.4 percent of the doses, or misused 51 of 140 total doses. Combined misuse of the digoxin and the diuretic was 36 percent, or 101 of 280 doses. Only one patient in Group I was found to have complied perfecdy.
In contrast, the seven instructed patients in Group II erred 7.9 percent, or misused 11 of 140 total doses of the digoxin. Errors involving the diuretic were nearly as low. These seven patients erred 8.6 percent, or 12 of 140 total doses. Combined, Group II had an error rate of 8.2 percent or misused 23 of 280 doses. Four of the seven patients in this group had perfect compliance.
The hyperlipoproteinemic sample results were not as definitive as those of the cardiac sample, yet differences seemed to exist between groups. Group III erred in the dosage of halofenate 6.5 percent, or 13 of 200 total doses were misused. The misuse rate of clofibrate was somewhat higher with a 13 percent error rate, or 52 of 400 total doses. These two drugs combined accounted for 10.8 percent of errors or 65 of 600 doses. Every patient in this group erred one or more times. Group IV appeared to have done better. Halofenate errors amounted to five percent, or 10 of 200 doses. Clofibrate errors were even less. The ten patients erred four percent, or 16 of 400 total doses. The errors of Group IV combined revealed a misuse rate of 4.3 percent, or 26 of 600 doses. Four patients in this group had perfect compliance.
Statistical analysis was applied to these results in testing the hypothesis: no difference exists between cardiac and hyperlipoproteinemic groups who receive instruction by a pharmacist and their respective control groups who do not receive such instruction. The Mann-Whitney U test was used to test the hypothesis at the five percent level.
The results, as shown in Tables 5 and 6 , permit rejection of the hypothesis. In the cardiac sample, a U of 11 or less would be significant at the five percent level. A U of 9.5 was obtained between these groups. A U of 27 or less was required for significance at the five percent 
PATIENT IDENTIFICATION AND INTERVIEW

Discussion
These results show that both cardiac and hyperlipoproteinemic groups who received instruction by the pharmacist/investigator made significantly fewer errors at the five percent level of confidence than their respective control groups who did not receive such instruction.
The difference in the number of errors committed among Groups I and II might be partially attributed to three patients in Group I. Patient 1 failed to have any prescriptions filled during his clinic visit. He had not been taking the daily doses of digoxin or the diuretic and therefore was assigned a total of 40 errors. This patient stated he was feeling well and "did not need the medication now." He retained the written prescription, however, to be filled at a later date if he felt a need for them.
Patient 7 took the digoxin as prescribed, but failed to have the diuretic filled thereby receiving 20 errors. This patient lived 50 miles from Tucson and often had his prescriptions filled at a local pharmacy near his home. This was his usual procedure because the restricted bus schedule to and from the clinic did not permit enough time to have the prescriptions filled at the hospital pharmacy. The convenience of the local pharmacy cost this patient the price of the prescriptions. He knew the digoxin was "important for my heart" and therefore paid for it, but refused to have other prescriptions filled because of financial reasons. This patient had not been informed that the hospital pharmacy mails medication to veterans who have difficulty in coming to the hospital.
Patient 5 had the prescriptions filled at the hospital pharmacy but failed to take the digoxin and therefore received 20 errors. When asked about the digoxin during the home interview, this patient could not remember taking such a drug. A five-minute search through a kitchen shelf containing between 40 and 50 old prescription containers partially filled with discontinued medication revealed the full bottle of digoxin. Apparently this patient's wife had stored the digoxin with her medication on the kitchen shelf. Perhaps because this patient did not know why he was given the digoxin, he quickly forgot he was told to take it.
Group II seemed to be free of any major errors. The investigator saw each patient following their appointment with the physician and personally filled their prescriptions. This procedure prevented any of the instructed patients from leaving the clinic without their prescribed medication. Each patient in Group II was also given instruction beyond that which is usually given by the physician. Consequently, emphasis placed upon the importance of observing the prescribed regimen at the time the medication was dispensed appears to have resulted in greater compliance.
Noncompliance among the hyperlipoproteinemic sample was extremely low if compared with this study's cardiac population or with other compliance studies cited in the literature. 1 ' 2 -4 This high compliance rate possibly could have been attributed to the design of the doubleblind study being conducted by Merck, Sharp and Dohme. Each patient admitted to the Merck, Sharp and Dohme study received a thorough physical examination and an extensive interview by one of the two physicians collecting the clinical data for the research. These patients also received explicit explanations concerning their medical condition and the purpose of the medication they were prescribed. Emphasis was placed upon the importance of taking the medication, and each patient was told to return the medication containers to each monthly clinic visit for replacement. Increased compliance may have Drug Intelligence and Clinical Pharmacy VOL 8 JULY 74
been a result of these factors in this specialized research. Interestingly, however, those patients who received additional reinforcement concerning their prescribed medication regimen from the pharmacist-investigator appeared to have an even higher rate of compliance than those patients who did not receive the additional instruction.
Conclusion
Despite the small number of outpatients in this study, the hypothesis which stated that no difference in medication errors exists between groups of cardiac and hyperlipoproteinemic outpatients who receive comprehensive instruction by a pharmacist and their respective control groups who do not receive such instruction, was rejected at the five percent level. Those patients who received instruction by the investigator/pharmacist made fewer errors than those patients who did not receive instruction. The results of this study reinforce the concept which expresses the need for clinically oriented pharmacists to provide drug information services directly to the patient. As shown by this investigation, the pharmacist can contribute to reducing medication errors by working with the physician in providing drug instruction and solving drug related problems which are ubiquitous in the outpatient clinic.
